B7+ T Cells in Myeloma: an Acquired Marker of Prior Chronic Antigen Presentation

References

• Chai, J.G., Vendetti, S., Amofah, E., Dyson, J. and Lechler, R. (2000) "CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation", Journal of Immunology, 165, 3037— 3042.
   Google Scholar
• Gimmi, C.D., Freeman, G.J., Gribben, J.G., Gray, G. and Nadler, L.M. (1993) "Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation", Proceedings of National Acadamy of Science of USA, 90, 6586–6590.
   PubMed Web of Science ®Google Scholar
• Guinan, E.C., Gribben, J.G., Boussiotis, V.A., Freeman, G.J. and Nadler, L.M. (1994) "Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumour immunity", Blood, 84, 3261 — 3283.
   Google Scholar
• June, C.H., Bluestone, J.A., Nadler, L.M. and Thompson, C.B. (1994) "The B7 and CD28 receptor families", Immunology Today, 15, 321–331.
   PubMedGoogle Scholar
• Linsley, P.S., Clark, E.A. and Ledbetter, J.A. (1990) "T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1", Proceedings of National Academy of Science USA, 87, 5031–5035.
   PubMed Web of Science ®Google Scholar
• Linsley, P.S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N.K. and Ledbetter, J.A. (1991) "Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation", Journal of Experimental Medicine, 173, 721 —730.
   Google Scholar
• Schultz, J., Nadler, L. and Gribben, J. (1996) "B7-mediated costimulation and the immune response", Blood Reviews, 10, 111 —127.
   Google Scholar
• Sotomayor, EM., Borrello, I., Rattis, F.M., Cuenca, AG., Abrams, J., Staveley-O'Carroll, K. and Levitsky, H. (2001) "Cross-presenta-tion of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression", Blood, 98, 1070–1077.
   PubMed Web of Science ®Google Scholar
• Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature, 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Sauter, B., Albert, ML., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N. (2000) "Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells", Journal of Experimental Medicine, 191, 423 —434.
   Google Scholar
• Wojtowicz-Praga, S. (1997) "Reversal of tumor-induced immuno-suppression: a new approach to cancer therapy", Journal of Immunotherapy, 20, 165 — 177.
   Google Scholar
• Brown, R.D., Pope, B., Murray, A., Gibson, J., Sze, M.D., Ho, P.J. and Joshua, D. (2001) "Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to upregulate CD80 (B7-1) expression after huCD4OLT stimulation due to inhibition by TGF/3 and IL-10. Blood, 98, 2992–2998.
   PubMed Web of Science ®Google Scholar
• Wolthers, K.C., Otto, S.A., Kolbach, D.N., van Lier, R.A., Miedema, F. and Meyaard, L. (1996) "Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4 T cells", European Journal of Immunology, 26, 1700 — 1706.
   Google Scholar
• Takasaki, Y., Abe, K., Tokano, Y. and Hashimoto, H. (1999) "The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy", Internal Medicine, 38, 175–177.
   PubMed Web of Science ®Google Scholar
• Sabzevari, H., Kantor, J., Jaigirdar, A., Tagaya, Y., Naramura, M., Hodge, J., Bernon, J. and Schlom, J. (2001) "Acquisition of CD80 (B7-1) by T cells", Journal of Immunology, 166, 2505— 2513.
   Google Scholar
• Chai, J.G., Bartok, I., Scott, D., Dyson, J. and Lechler, R. (1998) "T:T antigen presentation by activated murine CD8 + T cells induces anergy and apoptosis", Journal of Immunology, 160, 3655 — 3665.
   Google Scholar
• Joshua, D.E., Penny, R., Matthews, J.P., Laidlaw, C.R., Gibson, J., Bradstock, K., Wolf, M. and Goldstein, D. (1997) "Australian Leukaemia Study Group myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma", British Journal of Haematology, 97, 38–45.
   Google Scholar
• Raitakari, M., Brown, RD., Sze, D., Yuen, E., Barrow, L., Nelson, M., et al. (2000) "T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells", British Journal of Haematology, 110, 203–209.
   Google Scholar
• Schlienger, K., Uyemura, K., Jullien, D., Sieling, P.A., Rea, T.H., Linsley, P.S., et al. (1998) "B7-1, but not CD28, is crucial for the maintenance of the CD4 + T cell responses in human leprosy", Journal of Immunology, 161, 2407–2413.
   PubMed Web of Science ®Google Scholar
• Behrens, L., Kershensteiner, M., Misgeld, T., Goebels, N., Wekerle, H. and Hohfeld, R. (1998) "Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions", Journal of Immunology, 161, 5943 — 5951.
   Google Scholar
• Lim, S.H. and Bailey-Wood, R. (1999) "Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma", International Journal of Cancer, 83, 215–222.
   Google Scholar
• Massaia, M., Borrione, P., Battaglio, S., Mariani, S., Beggiato, E., Napoli, P., et al. (1999) "Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy", Blood, 94, 673–683.
   Google Scholar
• Reichardt, V.L., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., et al. (1999) "Idiotype vaccina-tion using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study", Blood, 93, 2411 — 2419.
   Google Scholar
• Ruffini, PA., Neelapu, S.S., Kwak, L. and Biragyn, A. (2002) "Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines", Haematologica, 87, 989–1001.
   Google Scholar
• Yi, Q., Desikan, R., Barlogie, B. and Munshi, N. (2002) "Optimizing dendritic cell-based immunotherapy in multiple mye-loma", British Journal of Haematology, 117, 297–305.
   Google Scholar
• Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., et al. (2000) "Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects", British Journal of Haematology, 108, 805–816.
   PubMed Web of Science ®Google Scholar
• Jorgensen, T., Gaudernack, G. and Hannestad, K. (1980) "Im-munization with the light chain and the VL domain of the isologous myeloma protein 315 inhibits growth of mouse plasmacytoma MOPC315", Scandinavian Journal of Immunology, 11, 29–35.
   PubMed Web of Science ®Google Scholar
• Zeis, M., Frenzke, H., Schmitz, N., Uharek, L. and Steinmann, J. (2002) "Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice", Bone Marrow Transplantation, 29, 213–221.
   Google Scholar
• Osterborg, A., Yi, Q., Bergenbrant, S., Holm, G., Lefvert, A.K. and Mellstedt, H. (1995) "Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests", British Journal of Haematology, 89, 110–116.
   Google Scholar
• Hwang, I., Huang, J.F., Kishimoto, H., Brunmark, A., Peterson, P.A., Jackson, MR., et al. (2000) "T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells", Journal of Experimental Medicine, 191, 1137 — 1148.
   Google Scholar
• Sze, D., Brown, R., Gibson, J., Ho, J., Yang, S., Pelka, G., et al. (2001) "Multiple myeloma idiotypic peptide-cytotoxic T cell interaction constitutes a minimal anti-tumor response", Blood, 98, 652a.
   Google Scholar
• Trojan, A., Schultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W., et al. (2002) "Immunoglobulin framework-derived peptides function as cytotoxic T cell epitopes commonly expressed in B cell malignancies", Nature Medicine, 6, 667–672.
   Google Scholar
• Bogen, B., Schenck, K., Munthe, L.A. and Dembic, Z. (2000) "Deletion of idiotype (Id)-specific T cells in multiple myeloma", Acta Oncolologica, 39, 783–788.
   Google Scholar
• Tomkins, MB., Bull, ME., Dow, J.L., Ball, J.M., Collisson, E.W., Winslow, B.J., et al. (2002) "Feline immunodeficiency virus infection is characterized by B7+ CTLA4 + T cell apoptosis", Journal of Infectious Diseases, 185, 1077–1093.
   PubMed Web of Science ®Google Scholar